{"id":"W3179687460","doi":"10.1016/j.thromres.2021.06.021","title":"Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study","year":2021,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Janssen Pharmaceuticals; Ministero della Salute; Janssen Scientific Affairs; Bayer","keywords":"Medicine; Rivaroxaban; Fondaparinux; Vitamin K antagonist; Cancer; Internal medicine; Dabigatran; Population; Venous thrombosis; Apixaban; Low molecular weight heparin; Venous thromboembolism; Thrombosis; Warfarin; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00319018,0.0004302071,0.000960389,0.0009281593,0.0005964254,0.001625391,0.0007016965,0.001572821,0.003230787],"category_scores_gemma":[0.009397715,0.0002682298,0.001777445,0.001577945,0.0003410049,0.001027553,0.001408008,0.001867133,0.0004295607],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005968076,"about_ca_system_score_gemma":0.0006858141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003835277,"about_ca_topic_score_gemma":0.003735754,"domain_scores_codex":[0.997896,0.0008526713,0.0003262492,0.0003059111,0.0004285219,0.0001906734],"domain_scores_gemma":[0.9950045,0.001054444,0.002302407,0.0002797457,0.0006245499,0.0007344413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005611212,0.001205182,0.9619163,0.001661102,0.005100816,0.0002312756,0.0007270888,0.0001913776,0.0001945622,0.0003812296,0.007496646,0.01528321],"study_design_scores_gemma":[0.0007461597,0.00130178,0.9913684,0.0005087304,0.001717508,0.0003567515,0.00070848,0.0002967236,0.00004165471,0.0001758608,0.002730157,0.00004781177],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9703864,0.01431778,0.0001033063,0.001939767,0.0002304057,0.0002859324,0.007015805,0.000007356035,0.005713331],"genre_scores_gemma":[0.991007,0.002764456,0.0001390992,0.0006430718,0.000302446,0.0002299103,0.004237199,0.000007268738,0.0006696471],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003835277,"threshold_uncertainty_score":0.01687145,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1175988438932322,"score_gpt":0.4234543630996354,"score_spread":0.3058555192064032,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}